Allarity Therapeutics, Inc.
Nasdaq · CIK 0001860657 · Fiscal year end 1231
Latest reported period: Latest published period
Operating Income
$-2.7M
Net Income
$-2.8M
Eps Basic
-0.17
Recent financials
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-2.7M | - | - |
| Net Income | $-2.8M | - | - |
| Eps Basic | -0.17 | - | - |
| Cash And Equivalents | $19.8M | - | - |
| Total Assets | $34.9M | - | - |
| Total Liabilities | $28.0M | - | - |
| Shareholders Equity | $6.9M | - | - |
| Operating Cash Flow | $-4.5M | - | - |
| Capital Expenditures | $64,000 | - | - |
Latest filings
| Form | Company | Filed | Accession |
|---|---|---|---|
| 10-Q | Allarity Therapeutics, Inc. | 2026-05-15 | 0001437749-26-017371 |
| 4 | Allarity Therapeutics, Inc. | 2026-05-14 | 0001213900-26-056373 |
| 4 | Allarity Therapeutics, Inc. | 2026-05-11 | 0001213900-26-054430 |
| 4 | Allarity Therapeutics, Inc. | 2026-05-07 | 0001213900-26-053466 |
| 4 | Allarity Therapeutics, Inc. | 2026-04-30 | 0001213900-26-050131 |
| 10-K | Allarity Therapeutics, Inc. | 2026-03-30 | 0001437749-26-010310 |
| 4 | Allarity Therapeutics, Inc. | 2026-01-16 | 0001213900-26-005146 |
| 10-Q | Allarity Therapeutics, Inc. | 2025-11-14 | 0001437749-25-035003 |
| 4 | Allarity Therapeutics, Inc. | 2025-10-02 | 0001213900-25-095391 |
| 10-Q | Allarity Therapeutics, Inc. | 2025-08-15 | 0001437749-25-027146 |